Safety of Soluble Beta-Glucan (SBG) in Treatment of Patients With Non-Hodgkin's Lymphoma
Status:
Completed
Trial end date:
2009-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety of soluble beta-glucan (SBG) in combination
with antibody and chemotherapy treatment in patients with non-Hodgkin-s lymphoma.